Reducing Blind Spots in the Pharma Supply Chain
by Suzanne Shelley, Pharmaceutical Technology
Expanded use of data analytics can help to avoid disruptions, but the possibilities cannot be realized without sufficient investment and direct human involvement.
It has become painfully clear in recent years that potential supply chain disruptions across all industries have become more the rule than the exception. Such disruptions arise when manufacturers experience short-term or prolonged shortages in raw materials, packaging materials, and/or critical components and are then unable to produce a reliable output of finished products or deliver them on time to their own downstream customers.
For pharma manufacturers, such issues increase business risk, create unnecessary costs and product losses, and increase the likelihood of
Read more...
|